Navigation Links
Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
Date:9/5/2007

ohnson & Johnson Pharmaceutical Research & Development. L.L.C.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) is part of Johnson & Johnson, the world's most broad-based producer of healthcare products. J&JPRD is headquartered in Raritan, New Jersey (USA), and has facilities throughout Europe and the United States. J&JPRD is leveraging drug discovery and drug development in a variety of therapeutic areas to address unmet medical needs worldwide.

About Ortho Biotech Products, L.P.

Ortho Biotech Products, L.P. is a leading biopharmaceutical company devoted to helping improve the lives of patients with cancer and with anemia due to multiple causes, including chronic kidney disease. Since it was founded in 1990, Ortho Biotech and its worldwide affiliates have earned a global reputation for researching, manufacturing and marketing innovative products that enhance patients' health. Located in Bridgewater, N.J., Ortho Biotech is an established market leader in Epoetin alfa therapy for anemia management. The company also markets treatments for recurrent ovarian cancer, rejection of transplanted organs and other serious illnesses. For more information, visit http://www.orthobiotech.com.


'/>"/>
SOURCE Ortho Biotech Products, L.P.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
2. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
6. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
7. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015  3-D printing could ... treatments to individual patient needs, with clinicians having ... size and shape. That,s according to a study ... Radiology ,s Annual Scientific Meeting . Researchers ... filaments that were bioactive, giving these devices the ...
(Date:3/3/2015)... March 3, 2015  KaVo Kerr Group, a global ... new products at the 36 th International Dental ... Kerr Group delivers products and solutions to 99% of ... trade fair for the dental industry — the ideal ... to offer. The meeting, March 10-14, 2015, expects more ...
(Date:3/3/2015)... 2015  CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... commercial focus on China , announces ... Executive Officer, will be making a corporate presentation at ... 8-11 in Dana Point, CA.  Dr. Ren will present ...
Breaking Medicine Technology:3-D printing offers innovative method to deliver medication 23-D printing offers innovative method to deliver medication 33-D printing offers innovative method to deliver medication 4KaVo Kerr Group Prepares to Present 35+ New Products at the 36th IDS in Cologne 2KaVo Kerr Group Prepares to Present 35+ New Products at the 36th IDS in Cologne 3CASI Pharmaceuticals To Present At The 27th Annual ROTH Conference 2
... OXIS International, Inc., (OTC Bulletin Board: OXIS ... Executive Officer, and Bernie Landes, President, will present to ... Sciences & Medical Technologies On-Line Forum on Thursday, February ... A webcast of the presentation will be ...
... Hardy Diagnostics, an ISO certified biomedical firm, is pleased ... selective chromogenic medium recommended for use as a primary ... Salmonella and Shigella spp. from stool ... non-pathogenic enteric bacteria based on colony color. Differentiation of ...
Cached Medicine Technology:The Only Chromogenic Medium That Detects Both Salmonella and Shigella! 2
(Date:3/3/2015)... 2015 Raritan Bay Medical Center is ... an interactive photo contest held at the Woodbridge Center ... To raise awareness for health and wellness in the ... their best health and wellness tips. , Photos of ... Center’s website and Facebook page where Facebook users voted ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Claflin ... the Department of Veterans Affairs has signed a new, ... March 1, 2015. , Under the contract, the ... such as the U.S. Military, Indian Health Services, National ... local government entities with competitive pricing for hospital equipment ...
(Date:3/3/2015)... A newly launched program is available ... II diabetes, and pre-diabetes. As opposed to traditional pharmaceutical ... for diabetes sufferers to reverse their disease without the ... In 2013, the U.S. diabetes industry made $250 billion ... include the use of insulin and other glucose-controlling medications ...
(Date:3/3/2015)... T-System Inc. today announced ... CPHQ, FABC as the company’s chief nursing officer along ... episodic care. , “Today’s patients are demanding ... including urgent care and freestanding emergency centers one of ... Davis, T-System’s chief executive officer. “We have a ...
(Date:3/3/2015)... March 03, 2015 The Data 360 ... at the Ford Conference Center, Dearborn, MI, on March 5, ... Inc., is a featured speaker. He is known internationally as ... , These designations were earned due to years of ... commercially-available NoSQL DB, released over 10 years ago. Subsequent developments ...
Breaking Medicine News(10 mins):Health News:Raritan Bay Medical Center Announces Winners of “Picture of Health” Photo Contest 2Health News:Claflin Medical Equipment (CME) Announces New 5 Year Contract with the Department of Veterans Affairs (VA) 2Health News:New Breakthrough In Diabetes Reaserch Show Scientifically Proven Way To Reverse Your Diabetes Naturally In 30 Short Days 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 4
... looking into Tamiflu; Relenza also under scrutiny. , , ... Food and Drug Administration panel is meeting Tuesday ... flu drug Tamiflu (oseltamivir), linked recently to anecdotal ... , The FDA,s Pediatric Advisory Committee will begin ...
... STORZ OR1(R) GIVES SURGEONS, GREATER ACCESS TO PATIENT DATA AND ... ... REMOTELY, ALISO VIEJO, Calif., Nov. 27 Global Care Quest, ... Inc., the world leader in minimally invasive,endoscopic technologies and operating room integration, ...
... Nov. 27 Merge Healthcare (Nasdaq:,MRGE; TSX: ... services provider,announced today that its Merge Healthcare ... Gold Seal of Approval(TM), by demonstrating,compliance with ... national standard for healthcare quality and safety. ...
... million Series A financing from Alta Partners, ... ProQuest Investments and RiverVest Venture Partners, CARLSBAD, ... Pharmaceuticals, Inc. (Nasdaq: ISIS ) and Excaliard ... and develop antisense,drugs for the local treatment of ...
... green product design granted the International HIDO ... Award, TORONTO, and GOLFE JUAN, France, Nov. ... specializing in sustainable and health,product innovations and HIDO, ... has received the HIDO,International Design Award. The Award ...
... MAR, Calif., Nov. 27 ,Awake, the movie is a,psychological ... awareness" and finds himself awake and aware, but paralyzed,during heart ... ,Coma, captured and terrified,the American public,s imagination. ,Coma, is the ... surgery -- and never wake up again., "Five years ...
Cached Medicine News:Health News:FDA Mulls Tougher Warning Label on Kids' Flu Drugs 2Health News:FDA Mulls Tougher Warning Label on Kids' Flu Drugs 3Health News:KARL STORZ and Global Care Quest Announce Extension of Marketing Agreement 2Health News:KARL STORZ and Global Care Quest Announce Extension of Marketing Agreement 3Health News:Merge Healthcare Teleradiology Division Receives Accreditation From Joint Commission 2Health News:Merge Healthcare Teleradiology Division Receives Accreditation From Joint Commission 3Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 2Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 3Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 4Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 5Health News:Cooler Solutions' 'Dignity Toilet' Wins International Design Competition by Providing Sanitation for Those in Need 2Health News:'Awake' the Movie Highlights the Need for 'Goldilocks' Anesthesia, Says Dr. Barry L. Friedberg, Developer of Bispectral Index (BIS) Monitored Propofol Ketamine Sedation, Now Trademarked as Minimally Invasive Anesthesia (MIA)(R) 2Health News:'Awake' the Movie Highlights the Need for 'Goldilocks' Anesthesia, Says Dr. Barry L. Friedberg, Developer of Bispectral Index (BIS) Monitored Propofol Ketamine Sedation, Now Trademarked as Minimally Invasive Anesthesia (MIA)(R) 3
... Oxygen Conservation Device. Bypass ... ,6200 Accessories: , OCD870C ... CGA 540 Regulator , OCD2001-18 ... Booklet , CP2140 Vertical M-6 ...
... with Accutrol is similar in design to ... it incorporates a temperature probe at the ... probe can accurately determine the patient's core ... temperature accuracy comparable to a pulmonary artery ...
... These markers are available with 16 or 24 circular ... diameter, and an outer 9.5mm diameter. The markers are ... one single step for a 16 or 24 running ... points on the cornea to achieve a precise and ...
... Shafts For Insertion Through A 1.0mm Incision., ... ... A More Comfortable Approach., ,Recessed Jaws For ... For Protection Of Jaws During Sterilization., ,Reusable, ...
Medicine Products: